These results revealed that post-transcriptional modulation such as C646-mediated histone deacetylation might participate in the repression of c-kit and bcl-2 levels, which accounted for the growth-inhibitory activity of C646 in AE-positive AML cells. The gene discussed is BCL2; the disease is acute myeloid leukemia.